ACADIA Pharmaceuticals (ACAD) Insider Trading & Ownership $22.30 +0.10 (+0.45%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$22.24 -0.05 (-0.25%) As of 06/11/2025 04:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACADIA Pharmaceuticals (NASDAQ:ACAD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage26.50%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$1.96M Get ACAD Insider Trade Alerts Want to know when executives and insiders are buying or selling ACADIA Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ACAD Insider Buying and Selling by Quarter ACADIA Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/4/2025Laura BregeDirectorSell14,446$21.78$314,633.88 5/16/2025James KiharaInsiderSell4,000$22.50$90,000.00 5/16/2025Mark C SchneyerEVPSell2,000$25.00$50,000.00 5/2/2025James KiharaInsiderSell1,327$14.60$19,374.20 5/2/2025Mark C SchneyerEVPSell3,498$14.60$51,070.80 4/8/2025James KiharaInsiderSell1,028$14.82$15,234.96 4/8/2025Mark C SchneyerEVPSell2,708$14.82$40,132.56 3/26/2025James KiharaInsiderSell1,095$17.05$18,669.75 3/26/2025Mark C SchneyerEVPSell3,171$17.05$54,065.55 3/5/2025Elizabeth A GarofaloDirectorSell4,919$18.23$89,673.37 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 2/24/2025James KiharaInsiderSell475$19.96$9,481.00 2/24/2025Mark C SchneyerCFOSell773$19.96$15,429.08 11/19/2024Brendan TeehanCOOSell10,329$16.81$173,630.49 11/19/2024James KiharaInsiderSell4,073$16.81$68,467.13 11/19/2024Mark C SchneyerCFOSell10,259$16.81$172,453.79 8/19/2024Brendan TeehanCOOSell9,534$15.28$145,679.52 8/19/2024Mark C SchneyerCFOSell9,733$15.28$148,720.24 8/19/2024Stephen DavisCEOSell31,747$15.28$485,094.16 (Data available from 1/1/2013 forward) ACAD Insider Trading Activity - Frequently Asked Questions Who is on ACADIA Pharmaceuticals's Insider Roster? The list of insiders at ACADIA Pharmaceuticals includes Austin D Kim, Brendan Teehan, Bros. Advisors Lp Baker, Elizabeth A Garofalo, James Kihara, Laura Brege, Mark C Schneyer, Srdjan R Stankovic, and Stephen Davis. Learn more on insiders at ACAD. What percentage of ACADIA Pharmaceuticals stock is owned by insiders? 26.50% of ACADIA Pharmaceuticals stock is owned by insiders. Learn more on ACAD's insider holdings. Which ACADIA Pharmaceuticals insiders have been selling company stock? The following insiders have sold ACAD shares in the last 24 months: Austin D Kim ($377,139.64), Brendan Teehan ($665,695.79), Elizabeth A Garofalo ($89,673.37), James Kihara ($488,970.76), Laura Brege ($426,548.88), Mark C Schneyer ($1,176,126.97), and Stephen Davis ($6,268,794.31). How much insider selling is happening at ACADIA Pharmaceuticals? Insiders have sold a total of 427,242 ACADIA Pharmaceuticals shares in the last 24 months for a total of $9,492,949.72 sold. ACADIA Pharmaceuticals Key ExecutivesMr. Stephen R. Davis J.D. (Age 63)President, CEO & Director Compensation: $1.46MMr. Mark C. Schneyer (Age 49)Executive VP & CFO Compensation: $701.03k5 recent tradesMr. Brendan P. Teehan (Age 55)Executive VP, COO & Head of Commercial Compensation: $724.31kMr. James K. Kihara (Age 43)VP, Chief Accounting Officer & Corporate Controller 5 recent tradesDr. Elizabeth H.Z. Thompson Ph.D. (Age 48)Executive VP & Head of Research and Development Mr. Benir RuanoSenior Vice President of Technical Development & OperationsMr. Albert S. KildaniSenior Vice President of Investor Relations & Corporate CommunicationsMs. Jennifer J. Rhodes J.D. (Age 54)Executive VP, Chief Legal Officer & Secretary Ms. Julie FisherSenior Vice President of Marketing & Commercial StrategyMs. Holly ValdiviezSenior VP & Head of Sales More Insider Trading Tools from MarketBeat Related Companies Intra-Cellular Therapies Insider Trades Genmab A/S Insider Trades Summit Therapeutics Insider Trades Moderna Insider Trades Viatris Insider Trades Blueprint Medicines Insider Trades Roivant Sciences Insider Trades Revolution Medicines Insider Trades Verona Pharma Insider Trades BridgeBio Pharma Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Tightly-Held Growth Stocks Set Up for Short SqueezesTankers, Takedowns & Air Taxis: Insiders Are Buying These 3 Names3 Tech Stocks Insiders Are Buying: Speculative Plays for JuneDividend Investors Looking for an Edge? 3 Stocks Insiders BoughtMeta's Institutional & Insider Data Fuels Bulls Despite Disparity This page (NASDAQ:ACAD) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGet Ready for Elon Musk’s BIGGEST Comeback YetTesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredAnother market crash is coming - here's whenMagnificent 7 Wipeout: What's Next? The first quarter stock crash and quick recovery has many people confus...Chaikin Analytics | SponsoredBillionaires are piling into this gold investmentBillionaires Are Piling into a Special Gold Investment With record gold prices, everyday Americans are scra...Weiss Ratings | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ACADIA Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ACADIA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACAD Stock Free ACAD Stock Alerts